Removal of erythrocyte membrane iron in vivo ameliorates the pathobiology of murine thalassemia

Journal of Clinical Investigation

Volumn 100, Issue 6, 1997, Pages 1459-1464

  Browne, Paul V ^a   Shalev, Oded ^a   Kuypers, Frans A ^b   Brugnara, Carlo ^c   Solovey, Anna ^a   Mohandas, Narla ^d   Schrier, Stanley L ^e   Hebbel, Robert P ^a,f  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

Chelation; Iron; Membrane; Red blood cell; Thalassemia

Indexed keywords

DEFERIPRONE; GLOBIN; HEMOGLOBIN; IMMUNOGLOBULIN; IRON; MEMBRANE PROTEIN; POTASSIUM;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE MEMBRANE; GENE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDRATION; MEAN CORPUSCULAR VOLUME; MOUSE; NONHUMAN; PRIORITY JOURNAL; THALASSEMIA;

EID: 0030822467     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119666     Document Type: Article

References (29)

1. Shinar, E., and E.A. Rachmilewitz. 1990. Oxidative denaturation of red blood cells in thalassemia. Semin. Hematol. 27:70-82.
2. Scott, M.D., J.J.M. van den Berg, T. Repka, P. Rouyer-Fessard, R.P. Hebbel, Y. Beuzard, and B.H. Lubin. 1993. Effect of excess α-hemoglobin chains on cellular and membrane oxidation in model β-thalassemic erythrocytes. J. Clin. Invest. 91:1706-1712.
3. Repka, T., O. Shalev, R. Reddy, J. Yuan, A. Abrahamov, E.A. Rachmilewitz, P.S. Low, and R.P. Hebbel. 1993. Nonrandom association of free iron with membranes of sickle and β-thalassemic erythrocytes. Blood. 82:3204-3210.
4. Advani, R., E. Rubin, N. Mohandas, and S.L. Schrier. 1992. Oxidative red blood cell membrane injury in the pathophysiology of severe mouse β-thalassemia. Blood. 79:1064-1067.
5. Olivieri, O., L. De Franceschi, M.D. Capellini, D. Girelli, R. Corrocher, and C. Brugnara. 1994. Oxidative damage and erythrocyte membrane transport abnormalities in thalassemias. Blood. 84:315-320.
6. Kuross, S.A., and R.P. Hebbel. 1988. Nonheme iron in sickle erythrocyte membranes: Association with phospholipids and potential role in lipid peroxidation. Blood. 72:1278-1285.
7. Repka, T., and R.P. Hebbel. 1991. Hydroxyl radical formation by sickle erythrocyte membranes: role of pathologic iron deposits and cytoplasmic reducing agents. Blood. 78:2753-2758.
8. Hebbel, R.P. 1990. The sickle erythrocyte in double jeopardy: autoxidation and iron decompartmentalization. Semin. Hematol. 27:51-69.
9. Olivieri, N.F., G.M. Brittenham, D. Matsui, M. Berkovitch, L.M. Blendis, R.G. Cameron, R.A. McClelland, P.P. Liu, D.M. Templeton, and G. Koren. 1995. Iron-chelation therapy with oral deferiprone in patients with thalassemia major. N. Engl. J. Med. 332:918-922.
10. Kontoghiorghes, G.J. 1988. Structure/red blood cell permeability, activity of iron(III) chelator complexes. Inorganic Chimica Acta. 151:101-106.
11. Shalev, O., T. Repka, A. Goldfarb, L. Grinberg, A. Abrahamov, N.F. Olivieri, E.A. Rachmilewitz, and R.P. Hebbel. 1995. Deferiprone (L1) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood cells both in vitro and in vivo. Blood. 86:2008-2013.
12. s and α-globins in transgenic mice: hemoglobin composition and hematological consequences. Proc. Natl. Acad. Sci. USA. 89: 12150-12154.
13. Skow, L.C., B.A. Burkhart, F.M. Johnson, R.A. Popp, D.M. Popp, S.Z. Goldberg, W.F. Anderson, L.B. Barnett, and S.E. Lewis. 1983. A mouse model for beta-thalassemia. Cell. 34:1043-1052.
14. Armsby, C.C., C. Brugnara, and S.L. Alper. 1995. Cation transport in mouse erythrocytes: Role of K+/Cl-cotransport in regulatory volume decrease. Am. J. Physiol (Cell Physiol. 37) 268:C894-C902.
15. Kuross, S., B.H. Rank, and R.P. Hebbel. 1988. Excess heme in sickle erythrocyte inside-out membranes: Possible role in thiol oxidation. Blood. 71: 876-882.
16. Rank, B., J. Carlsson, and R.P. Hebbel. 1985. Abnormal redox status of membrane-protein thiols in sickle erythrocytes. J. Clin. Invest. 75:1531-1537.
17. Hoffman-Fezer, G., J. Mysliwietz, W. Mörtbauer, H.J. Zeitler, E. Eberle, U. Hönle, and S. Thierfelder. 1993. Biotin labeling as an alternative nonradioactive approach to determination of red cell survival. Ann. Hematol. 67:81-87.
18. Clark, M.R., N. Mohandas, and S. Shohet. 1983. Osmotic gradient ektacytometry: comprehensive characterization of red cell volume and surface maintenance. Blood. 61:899-910.
19. Shinar, E., E.A. Rachmilewitz, and S.E. Lux. 1989. Differing erythrocyte membrane skeletal protein defects in alpha and beta thalassemia. J. Clin. Invest. 83:404-410.
20. Rouyer-Fessard, P., M.-C. Garel, C. Domenget, D. Guetarni, D. Bachir, P. Colonna, and Y. Beuzard. 1989. A study of membrane protein defects and α hemoglobin chains of red blood cells in human β thalassemia. J. Biol. Chem. 264:19092-19098.
21. Rouyer-Fessard, P., K. Leroy-Viard, C. Domenget, A. Mrad, and Y. Beuzard. 1990. Mouse β thalassemia, a model for the membrane defects of erythrocytes in the human disease. J. Biol. Chem. 265:20247-20251.
22. Advani, R., S. Sorenson, E. Shinar, W. Lande, E. Rachmilewitz, and S.L. Schrier. 1992. Characterization and comparison of the red blood cell membrane damage in severe human α-and β-thalassemia. Blood. 79:1058-1063.
23. Schrier, S., E. Rachmilewitz, and N. Mohandas. 1989. Cellular and membrane properties of alpha and beta thalassemic erythrocytes are different: implication for differences in clinical manifestations. Blood. 74:2194-2202.
24. De Franceschi, L., O. Shalev, A. Piga, M. Collell, O. Olivieri, R. Corrocher, R.P. Hebbel, N. Olivieri, and C. Brugnara. 1996. Deferiprone (L1) treatment removes erythrocyte membrane free iron and affects K-Cl cotransport activity in homozygous β thalassemia. Blood. 88 (Suppl.):24b.
25. Yuan, J., R. Kannan, E. Shinar, E.A. Rachmilewitz, and P.S. Low. 1992. Isolation, characterization, and immunuprecipitation studies of immune complexes from membranes of β-thalassemic erythrocytes. Blood. 79:3007-3013.
26. Shalev, O., and R.P. Hebbel. 1996. Catalysis of soluble hemoglobin oxidation by free iron on sickle red cell membranes. Blood. 87:3948-3952.
27. Thevenin, B.J.-M., B.M. Willardson, and P.S. Low. 1989. The redox state of cysteines 201 and 317 of the erythrocyte anion exchanger is critical for ankyrin binding. J. Biol. Chem. 264:15886-15892.
28. Olivieri, N. 1996. Long-term therapy with deferiprone. Acta Haematologica. 95:37-48.
29. Hebbel, R.P. 1991. Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology. Blood. 77:214-237.